Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents: A cross-sectional study

Sexually Transmitted Diseases

Volumn 34, Issue 8, 2007, Pages 563-569

  Franceschi, Silvia ^a   Smith, Jennifer S ^b   Van Den Brule, Adriaan ^c   Herrero, Rolando ^d   Arslan, Annie ^a   Anh, Pham Thi Hoang ^e   Bosch, F Xavier ^f   Hieu, Nguyen Trong ^g   Matos, Elena ^h   Posso, Hector ⁱ   Qiao, You Lin ^j   Shin, Hai Rim ^k   Sukvirach, Sukhon ^l   Thomas, Jaiye O ^m   Snijders, Peter J F ⁿ   Muñoz, Nubia ^j   Meijer, Chris J L M ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b IL   (United States)

^c Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^d PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^e National Cancer Institute   (Viet Nam)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g Hung Vuong Hospital   (Viet Nam)

^h Instituto de Oncologia Angel H Roffo   (Argentina)

ⁱ Instituto Nacional de Cancerología   (Colombia)

^j PEKING UNION MEDICAL COLLEGE   (China)

^k National Cancer Center   (South Korea)

^l NATIONAL CANCER INSTITUTE   (Thailand)

^m UNIVERSITY OF IBADAN   (Nigeria)

ⁿ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; CHINA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GONORRHEA; HIGH RISK POPULATION; HUMAN; INFECTION RISK; KOREA; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NEISSERIA GONORRHOEAE; NIGERIA; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; SPAIN; THAILAND; UTERINE CERVICITIS; VIET NAM; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; ASIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COLOMBIA; CROSS-SECTIONAL STUDIES; FEMALE; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE; NIGERIA; PREVALENCE; RISK FACTORS; SPAIN; UTERINE CERVICAL DISEASES;

EID: 34547622800     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000258417.66619.0e     Document Type: Article

References (36)

1. World Health Organisation. Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates. Geneva: WHO; 2001.
2. Health Protection Agency. Focus on prevention of HIV and other sexually transmitted infections in the United Kingdom in 2003. Annual Report. London: Health Protection Agency; 2004.
3. Franceschi S, Herrero R, Clifford G, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006; 119:2677-2684.
4. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer; 2002.
5. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 64: Human papillomavirus. Lyon: International Agency for Research on Cancer; 1995.
6. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 2004; 90:638-645.
7. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87:324-333.
8. Matos E, Loria D, Amestoy G, et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: A population-based study. Sex Transm Dis 2003; 30:593-599.
9. Anh PT, Hieu NT, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003; 104:213-220.
10. Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: A population-based study. Br J Cancer 2006; 95:96-101.
11. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003; 187:1246-1256.
12. Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003; 103:413-421.
13. de Sanjosé S, Almirall R, Lloveras B, et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003; 30:788-793.
14. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 2005; 366:991-998.
15. Van Doornum GJ, Schouls LM, Pijl A, et al. Comparison between the LCx probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol 2001; 39:829-835.
16. Boel CH, van Herk CM, Berretty PJ, et al. Evaluation of conventional and real-time PCR assays using two targets for confirmation of results of the COBAS AMPLICOR Chlamydia trachomatis/eisseria gonorrhoeae test for detection of Neisseria gonorrhoeae in clinical samples. J Clin Microbiol 2005; 43:2231-2235.
17. Jacobs MV, Walboomers JM, Snijders PJ, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87:221-227.
18. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527.
19. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229-2236.
20. Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted infections in South Africa: A review. Sex Transm Infect 2005; 81:287-293.
21. Burstein GR, Snyder MH, Conley D, et al. Chlamydia screening in a health plan before and after a national performance measure introduction. Obstet Gynecol 2005; 106:327-334.
22. Gerbase AC, Rowley JT, Heymann DH, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74 (Suppl 1):S12-S16.
23. Wilson JS, Honey E, Templeton A, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 2002; 8:385-394.
24. Burstein GR, Zenilman JM, Gaydos CA, et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect 2001; 77:26-32.
25. Krzyzaniak LT, Lotfy M. The rise and fall of IUDS's: Banning of IUD's in USA. Alarming interactions between IUD's and sexually transmitted diseases (STD). Adv Contracept Deliv Syst 1986; 2:112-158.
26. Louv WC, Austin H, Perlman J, et al. Oral contraceptive use and the high risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989; 160:396-402.
27. Cottingham J, Hunter D. Chlamydia trachomatis and oral contraceptive use: A quantitative review. Genitourin Med 1992; 68:209-216.
28. Radcliffe KW, Ahmad S, Gilleran G, et al. Demographic and behavioural profile of adults infected with chlamydia: A case-control study. Sex Transm Infect 2001; 77:265-270.
29. Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: The importance of assessing partner infection status. Am J Epidemiol 2004; 159:242-251.
30. Samoff E, Koumans EH, Markowitz LE, et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162:668-675.
31. Wallin KL, Wiklund F, Luostarinen T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002; 101:371-374.
32. Smith JS, Bosetti C, Muñoz N, et al. Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004; 111:431-439.
33. Watson EJ, Templeton A, Russell I, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: A systematic review. J Med Microbiol 2002; 51:1021-1031.
34. Svensson LO, Domeika M, Mardh PA. Cervical sampling for diagnosis of genital chlamydial infection with a new brush device. Genitourin Med 1993; 69:397-399.
35. Herold AH, Young DL, Wightman JK, et al. Comparison of the cytology brush with the Dacron swab for detecting Chlamydia trachomatis by enzyme immunoassay in female university students. J Am Coll Health 1993; 41:213-216.
36. Schachter J, McCormack WM, Chernesky MA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003; 41:3784 -3789.